首页> 美国卫生研究院文献>BMC Cancer >Thoracic perfusion of recombinant human endostatin (Endostar) combined with chemotherapeutic agents versus chemotherapeutic agents alone for treating malignant pleural effusions: a systematic evaluation and meta-analysis

【2h】

Thoracic perfusion of recombinant human endostatin (Endostar) combined with chemotherapeutic agents versus chemotherapeutic agents alone for treating malignant pleural effusions: a systematic evaluation and meta-analysis

机译：胸腔灌注重组人内皮抑素（Endostar）联合化学治疗药物与单独使用化学治疗药物治疗恶性胸腔积液：系统评价和荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundEndostar is a new endogenous angiogenic inhibitor with implicated anti-tumor activity. This study was to investigate whether thoracic perfusion of Endostar could be used to control malignant pleural effusions (MPE).

机译：背景Endostar是一种新型的内源性血管生成抑制剂，具有抗肿瘤活性。这项研究旨在调查Endostar的胸腔灌注是否可用于控制恶性胸腔积液（MPE）。

著录项

期刊名称 BMC Cancer
作者
Rong Biaoxue; Cai Xiguang; Liu Hua; Gao Wenlong; Yang Shuanying;
展开▼
作者单位

展开▼
年(卷),期 2016(16),-1
年度 2016
页码 888
总页数 13
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
Endostar Malignant pleural effusions MPE Meta-analysis Efficacy Safety;

机译：Endostar;恶性胸腔积液;MPE;Meta分析;疗效;安全性;

相似文献

外文文献
中文文献
专利

1. Thoracic perfusion of recombinant human endostatin (Endostar) combined with chemotherapeutic agents versus chemotherapeutic agents alone for treating malignant pleural effusions: a systematic evaluation and meta-analysis [J] . Rong Biaoxue, Cai Xiguang, Liu Hua, BMC Cancer . 2016,第1期

机译：胸腔灌注重组人内皮抑素（Endostar）联合化学治疗药物与单独使用化学治疗药物治疗恶性胸腔积液：系统评价和荟萃分析
2. Evaluation of efficacy and safety for recombinant human adenovirus-p53 in the control of the malignant pleural effusions via thoracic perfusion [J] . Rong Biaoxue, Pan Hui, Gao Wenlong, Scientific reports. . 2016,第1期

机译：通过胸灌注对重组人腺病毒-P53进行重组人腺病毒-P53的疗效和安全性评估
3. Systematic review and meta-analysis of Endostar (rh-endostatin) combined with chemotherapy versus chemotherapy alone for treating advanced non-small cell lung cancer [J] . Rong Biaoxue, Yang Shuanying, Li Wei, World Journal of Surgical Oncology . 2012,第1期

机译：系统评价和荟萃分析Endostar（rh-endostatin）联合化疗与单纯化疗联合治疗晚期非小细胞肺癌
4. EVALUATION OF BIOFLAVONOIDS AS POTENTIAL CHEMOTHERAPEUTIC AGENTS [C] . Katie Womack, Maxine Anderson, Michelle Tucci, Annual Rocky Mountain Bioengineering Symposium . 2006

机译：评估生物脂醛作为潜在的化学治疗剂
5. Design, synthesis and biological evaluation of human inosine 5'-monophosphate dehydrogenase inhibitors: 1,5-diazabicyclo(3.1.0)hexane-2,4-diones, as novel isozyme-selective cancer chemotherapeutic agents. [D] . Barnes, Betsy Jo. 1999

机译：人肌苷5'-单磷酸脱氢酶抑制剂的设计，合成和生物学评估：1,5-二氮杂双环（3.1.0）己烷-2,4-二酮，作为新型的同工酶选择性癌症化学治疗剂。
6. Recombinant Human Endostatin Endostar Suppresses Angiogenesis and Lymphangiogenesis of Malignant Pleural Effusion in Mice [O] . Xingqun Ma, Yanwen Yao, Dongmei Yuan, 2009

机译：重组人内皮抑素Endostar抑制小鼠恶性胸腔积液的血管生成和淋巴管生成。
7. Thoracic perfusion of recombinant human endostatin (Endostar) combined with chemotherapeutic agents versus chemotherapeutic agents alone for treating malignant pleural effusions: a systematic evaluation and meta-analysis [O] . 2016

机译：胸腔灌注重组人内皮抑素（Endostar）联合化学治疗药物与单独使用化学治疗药物治疗恶性胸腔积液：系统评价和荟萃分析
8. SURVIVAL OF CLONOGENIC CELLS FROM A MURINE SOLID TUMOR TREATED IN VIVO WITH RADIATION AND CHEMOTHERAPEUTIC AGENTS [R] . Moody D. Wharam, Theodore L. Phillips, Lawrence Kane 1973

机译：用放射和化学治疗剂治疗体内治疗的小鼠固体瘤的克隆细胞存活率

Thoracic perfusion of recombinant human endostatin (Endostar) combined with chemotherapeutic agents versus chemotherapeutic agents alone for treating malignant pleural effusions: a systematic evaluation and meta-analysis

摘要

著录项

相似文献

相关主题

期刊订阅